Dorton Katina

NONE · Director

Dorton Katina is listed in public filings as director. This Dorton Katina insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Class I Common Stock, par value $0.001 per share (NONE), TScan Therapeutics, Inc. (TCRX), and Fulcrum Therapeutics, Inc. (FULC). Investors use Dorton Katina's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Class I Common Stock, par value $0.001 per shareNONE--7.4k sharesGrant / ExerciseJun 2, 2026Disclosure amount unavailable4.9k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
TScan Therapeutics, Inc.TCRX$67k67k sharesGrant / ExerciseMay 20, 2026$66.6K67k shares$0.9946--
Class I Common Stock, par value $0.001 per shareNONE--31.9k sharesGrant / ExerciseFeb 23, 2026Disclosure amount unavailable4k shares----
Class I Common Stock, par value $0.001 per shareNONE--2.5k sharesGrant / ExerciseJan 1, 2026Disclosure amount unavailable513 shares----
Class I Common Stock, par value $0.001 per shareNONE--3k sharesGrant / ExerciseJan 1, 2026Disclosure amount unavailable1.8k shares----
Class I Common Stock, par value $0.001 per shareNONE--29.7k sharesOtherJan 1, 2026Disclosure amount unavailable1.5k shares----
Class I Common Stock, par value $0.001 per shareNONE--25.9k sharesGrant / ExerciseAug 14, 2025Disclosure amount unavailable4.1k shares----
Class I Common Stock, par value $0.001 per shareNONE--21.9k sharesGrant / ExerciseJul 31, 2025Disclosure amount unavailable16.4k shares----
TScan Therapeutics, Inc.TCRX$97k67k sharesGrant / ExerciseJun 30, 2025$97.2K67k shares$1.45--
Fulcrum Therapeutics, Inc.FULC$266k36k sharesGrant / ExerciseJun 26, 2025$265.7K36k shares$7.38--
Fulcrum Therapeutics, Inc.FULC$210k30k sharesGrant / ExerciseJun 17, 2024$210.0K30k shares$7.00--
TScan Therapeutics, Inc.TCRX$422k47.5k sharesGrant / ExerciseJun 12, 2024$421.8K47.5k shares$8.88--